Back to results
US 2026/0256828 A1Published application
1,4-polyisoprene dispersion system, pharmaceutical active ingredient and use thereof
AssigneeSuzhou Haiyi Biomedical Technology Co. Ltd.
InventorsYixin Zhu, Yuanli Chen, Xiaoxiao Yang, Shuang Xu
Life of this patent
Estimating the term…
Abstract
A 1,4-polyisoprene dispersion system is selected from a 1,4-polyisoprene solution dispersion system and a 1,4-polyisoprene emulsion dispersion system. The 1,4-polyisoprene solution dispersion system includes 1,4-polyisoprene and a solvent. The 1,4-polyisoprene emulsion dispersion system includes 1,4-polyisoprene, an emulsifier, and water.
Claims19
A 1,4-polyisoprene dispersion system,
- wherein the 1,4-polyisoprene dispersion system remains stable in a mammalian gastric acid environment without clot formation of 1,4-polyisoprene, absence of oral toxicity in mammals, and being free from allergens.
(canceled)
Dependencies are inferred from the claim text.